
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **S100A7**: Known for its role in inflammation and immune response, often associated with epithelial cells.<br>- **TFF1, TFF3**: Trefoil factors involved in mucosal protection and repair, commonly expressed in epithelial tissues.<br>- **AREG (Amphiregulin)**: A growth factor involved in epithelial cell proliferation.<br>- **MUC1**: A mucin protein that plays a role in forming protective mucous barriers on epithelial surfaces.<br>- **FASN (Fatty Acid Synthase)**: Involved in lipid biosynthesis, often upregulated in cancer cells.<br>- **CLDN3 (Claudin 3)**: A component of tight junctions in epithelial cells.<br>- **KRT18, KRT8, KRT19**: Keratins typically expressed in epithelial cells, particularly luminal epithelial cells.<br>- **S100P**: Involved in calcium binding, often expressed in epithelial cells and associated with cancer progression.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT18, KRT8, KRT19**: These keratins are markers for luminal epithelial cells, commonly found in breast tissue.<br>- **MUC1**: A marker for epithelial cells, particularly in glandular tissues like the breast.<br>- **CLDN3**: Often expressed in epithelial cells, including those in breast tissue.<br>- **S100A7, S100P**: Markers associated with epithelial cells and often upregulated in breast cancer.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas and literature on breast cancer scRNA-seq, these markers are consistent with epithelial cells, particularly luminal epithelial cells in breast tissue. The presence of keratins (KRT18, KRT8, KRT19) and MUC1 strongly suggests a luminal epithelial origin.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of these markers, the most likely general cell type is **epithelial cells**, specifically those associated with the luminal lineage in breast tissue.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Epithelial Cells**: The expression of KRT18, KRT8, KRT19, and MUC1 strongly supports this subtype, which is a major component of breast tissue.<br>2. **Luminal Progenitor Cells**: These cells also express similar keratins and are involved in the differentiation process within the breast epithelium.<br>3. **Basal-like Epithelial Cells**: Although less likely due to the specific keratin expression, they can sometimes express overlapping markers in certain contexts.<br><br>The most likely subtype based on the markers is **Luminal Epithelial Cells**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of epithelial cells, specifically luminal epithelial cells. This conclusion is supported by the expression of key markers such as KRT18, KRT8, KRT19, and MUC1, which are characteristic of luminal epithelial cells in breast tissue. These cells play a crucial role in the structure and function of the mammary gland and are often implicated in breast cancer.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency**: <br>   - The key functional markers and cell type markers listed in the annotation (S100A7, TFF1, TFF3, AREG, MUC1, FASN, CLDN3, KRT18, KRT8, KRT19, S100P) are all present in the provided marker list.<br>   - These markers are well-known to be associated with epithelial cells, particularly luminal epithelial cells, which are common in breast tissue.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation considers the possibility of mixed cell types by listing luminal epithelial cells, luminal progenitor cells, and basal-like epithelial cells as potential subtypes. However, the markers strongly support luminal epithelial cells as the primary subtype.<br>   - There is no strong evidence from the marker list to suggest the presence of multiple distinct cell types that would require further investigation.<br><br>Overall, the annotation aligns well with the marker list and the known biology of breast tissue, specifically the luminal epithelial lineage.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Luminal Epithelial Cells</li><li>Luminal Progenitor Cells</li><li>Basal-like Epithelial Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a strong understanding of the marker list and its implications for identifying cell types within the context of human breast cancer. The analysis correctly identifies the main cell type as epithelial cells, with a specific focus on luminal epithelial cells, which is consistent with the expression of key markers such as KRT18, KRT8, KRT19, and MUC1. These markers are well-known to be associated with luminal epithelial cells in breast tissue, supporting the annotation's accuracy.<br><br>The annotation process shows a balanced consideration of multiple markers, rather than over-focusing on a specific one. For instance, the inclusion of markers like S100A7, TFF1, TFF3, AREG, and CLDN3, alongside the keratins, provides a comprehensive view of the epithelial nature of the cells. This approach ensures that the annotation captures the general picture of the cell populations present in the dataset.<br><br>The annotation also considers the possibility of mixed cell types by listing luminal progenitor cells and basal-like epithelial cells as potential subtypes. However, the markers strongly support luminal epithelial cells as the primary subtype, which aligns with the known biology of breast tissue and breast cancer. The analysis does not overlook any obvious markers that would suggest a different primary cell type, and there are no apparent misclassifications.<br><br>One potential area for improvement could be a more explicit consideration of the rank of the markers, as markers appearing earlier in the list might hold more significance. However, the overall annotation remains scientifically accurate and provides a comprehensive view of the cell types present.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    